We are live on ! Find out more
ACER

Acer Therapeutics Inc

Delisted

ACER was delisted on the 8th of November, 2023.

27 hedge funds and large institutions have $3.49M invested in Acer Therapeutics Inc in 2023 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 7 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

16% less funds holding

Funds holding: 3227 (-5)

29% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 7

43% less capital invested

Capital invested by funds: $6.14M → $3.49M (-$2.66M)

44% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 9

92% less call options, than puts

Call options by funds: $2K | Put options by funds: $24K

Holders
27
Holders Change
-5
Holders Change %
-15.63%
% of All Funds
0.43%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
5
Reduced
7
Closed
9
Calls
$2K
Puts
$24K
Net Calls
-$22K
Net Calls Change
-$191K
Name Holding Trade Value Shares
Change
Change in
Stake
DMKJ
26
David M. Knott Jr
-$351K -140,000 Closed
TSS
27
Two Sigma Securities
New York
-$49.6K -19,747 Closed
SW
28
SVB Wealth
Massachusetts
-$28.9K -11,500 Closed
VF
29
Virtu Financial
New York
-$26K -10,557 Closed
Two Sigma Advisers
30
Two Sigma Advisers
New York
-$26.1K -10,400 Closed
Citadel Advisors
31
Citadel Advisors
Florida
-$1.67K -847 Closed
Group One Trading
32
Group One Trading
Illinois
-$1.34K -680 Closed
BNP Paribas Financial Markets
33
BNP Paribas Financial Markets
France
-$449 -179 Closed
Bank of America
34
Bank of America
North Carolina
-$66 -26 Closed
SS
35
Sunbelt Securities
Texas
+$1.58K +800 New

ACER Hedge Fund Activity: Q1 2023 in Review

27 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in Acer Therapeutics Inc (ACER) for Q1 2023, worth a combined $3.49M — down 43% from $6.14M a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of ACER and 5 opened new positions — a net loss of 4 holders — while 7 trimmed existing stakes and 5 added.

The largest buyer was Armistice Capital, opening a new position worth an estimated $4.35M. The largest seller was David M. Knott Jr, exiting entirely with an estimated $351K sold.

  • 27 institutional investors held Acer Therapeutics Inc (ACER) as of Q1 2023, down from 32 in Q4 2022.
  • Funds reported $3.49M of Acer Therapeutics Inc stock for Q1 2023, down 43% quarter-over-quarter.
  • 5 funds opened new Acer Therapeutics Inc positions in Q1 2023 and 9 closed out, a net change of -4 holders.
  • The largest Acer Therapeutics Inc buyer in Q1 2023 was Armistice Capital, an estimated $4.35M added.
  • The largest Acer Therapeutics Inc seller in Q1 2023 was David M. Knott Jr, an estimated $351K sold.

Based on aggregated 13F filings for Q1 2023.